The Nucleoside/Nucleotide Analogs Tenofovir and Emtricitabine Are Inactive against SARS-CoV-2 |
| |
| Authors: | Joy Y. Feng,Venice Du Pont,Darius Babusis,Calvin J. Gordon,Egor P. Tchesnokov,Jason K. Perry,Vincent Duong,Arya Vijjapurapu,Xiaofeng Zhao,Julie Chan,Cal Cohen,Kavita Juneja,Tomas Cihlar,Matthias Gö tte,John P. Bilello |
| |
| Affiliation: | 1.Gilead Sciences, Inc., Foster City, CA 94404, USA; (V.D.P.); (D.B.); (J.K.P.); (V.D.); (A.V.); (X.Z.); (J.C.); (C.C.); (K.J.); (T.C.); (J.P.B.);2.Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB T6G 2E1, Canada; (C.J.G.); (E.P.T.); (M.G.) |
| |
| Abstract: | |
| |
| Keywords: | SARS-CoV-2 HIV-1 NRTI tenofovir TAF TDF FTC |
|
|
